Candida auris - recommendations on infection prevention and control measures in Switzerland.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
21 Sep 2020
Historique:
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 19 8 2021
Statut: epublish

Résumé

Candida auris, a globally emerging pathogen, has been repeatedly introduced into European healthcare settings, leading to large and long-lasting nosocomial outbreaks. The pathogen has already been isolated in Switzerland, requiring clinicians and microbiologists to become alert. This is the first comprehensive guidance document on prevention and control of C. auris in Swiss acute care hospitals. It brings to light the most recent evidence from published original articles and reviews. We emphasise the importance of quickly identifying this yeast by means of screening in order to prevent an outbreak that could be difficult to contain. Key containment strategies include reinforcing early detection, hand hygiene, application of strict contact precautions for colonised and infected patients, and thorough specific environmental cleaning and disinfection.

Identifiants

pubmed: 32975306
doi: 10.4414/smw.2020.20297
pii: Swiss Med Wkly. 2020;150:w20297
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20297

Auteurs

Danielle Vuichard-Gysin (D)

Department of Internal Medicine, Division of Infectious Diseases, Thurgau Hospital Group, Switzerland.

Rami Sommerstein (R)

Department of Infectious Diseases, Bern University Hospital, University of Bern, Switzerland.

Romain Martischang (R)

Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

Stephan Harbarth (S)

Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

Stefan P Kuster (SP)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.

Laurence Senn (L)

Service of Hospital Preventive Medicine, Lausanne University Hospital, Switzerland.

Andreas Widmer (A)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH